Ardent Health, Inc. filed an 8-K to revise its non-GAAP financial measures in its 2025 Form 10-K following discussions with SEC staff. The company removed $97.7 million in aggregate adjustments related to a change in accounting estimate for accounts receivable collectability and a New Mexico professional liability accrual from its Adjusted EBITDA and Adjusted EBITDAR calculations. Consequently, the reported Adjusted EBITDA for the year ended December 31, 2025 decreased from $545.0 million to $447.3 million, while Adjusted EBITDAR fell from $709.3 million to $611.6 million. The filing confirms that GAAP net income and cash flows remain unchanged, with no impact on 2023 or 2024 results or 2026 financial projections. Ardent Health operates a network of acute care hospitals and medical office buildings in the healthcare industry.

Ardent Health, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026. Total revenue declined 1.4% year-over-year to $1.62 billion, while net income attributable to Ardent Health fell to $17 million, or $0.12 per diluted share, compared to $73 million in the prior year period. Adjusted EBITDA decreased 32.3% to $115 million due to lower surgeries and admissions, though volumes improved after an intra-quarter update. The company reported strong operating cash flow of $197 million, a 67% increase year-over-year. Ardent Health reaffirmed its full-year 2026 revenue guidance of $6.4 billion to $6.7 billion and Adjusted EBITDA guidance of $485 million to $535 million. The company operates in the healthcare industry, providing acute care hospital services through a network of facilities across the United States.

Martin J. Bonick departed from his role as President and Chief Executive Officer of Ardent Health, Inc. effective June 2, 2026. Following his departure, the company entered into a separation agreement and general release with Mr. Bonick on June 26, 026, which includes severance benefits consistent with a termination without cause. Ardent Health, Inc. is a healthcare services provider.

Ardent Health, Inc. appointed Dave Caspers as President and Chief Executive Officer, succeeding Martin J. Bonick, effective June 2, 2026. Mr. Caspers' compensation includes an annual base salary of $900,000 with a 105% target bonus, as well as special one-time equity grants of $1,050,000 in time-based RSUs and $1,950,000 in performance-based RSUs.